- Home
- CMS vs IQV Comparison
CMS vs IQV Comparison
Compare CMS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMS | IQV |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | United States | United States |
| Employees | 8350 | 93000 |
| Industry | Power Generation | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5B | 27.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | CMS | IQV |
|---|---|---|
| Price | $77.19 | $169.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | $78.38 | ★ $230.56 |
| AVG Volume (30 Days) | ★ 2.2M | 1.4M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.95% | N/A |
| EPS Growth | N/A | ★ 4.67 |
| EPS | N/A | ★ 7.84 |
| Revenue | N/A | ★ $9,739,000,000.00 |
| Revenue This Year | $2.06 | $6.77 |
| Revenue Next Year | $4.67 | $5.87 |
| P/E Ratio | $21.28 | ★ $21.22 |
| Revenue Growth | N/A | ★ 41.60 |
| 52 Week Low | $67.71 | $134.65 |
| 52 Week High | $78.88 | $247.05 |
Technical Indicators
Market Signals| Indicator | CMS | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 56.84 | 46.11 |
| Support Level | $69.17 | $157.59 |
| Resistance Level | $78.68 | $170.89 |
| Average True Range (ATR) | 1.31 | 5.97 |
| MACD | -0.11 | 1.37 |
| Stochastic Oscillator | 65.25 | 63.31 |
Price Performance
Historical ComparisonAbout CMS CMS Energy Corporation
CMS Energy is an energy holding company with three principal businesses. Its regulated utility, Consumers Energy, provides regulated natural gas service to 1.8 million customers and electric service to 1.9 million customers in Michigan. NorthStar Clean Energy, formerly CMS Enterprises, is engaged in wholesale power generation, including contracted renewable energy. CMS sold EnerBank in October 2021.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.